Ensign Group (ENSG)

Nasdaq Health Care Health Care Facilities S&P MidCap 400
$181.08
-1.31 (-0.72%)
Close of Nov 06, 2026 · end-of-day data
Source: Ensign Group's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$1.65B$1.60B$1.75B$2.04B$2.39B$2.63B$3.03B$3.71B$4.24B$5.03B
Cost of revenue$1.34B$1.31B$1.42B$1.62B$1.87B$2.02B$2.35B$2.94B$3.38B$4.02B
Gross profit$313.05M$284.88M$336.35M$415.90M$522.24M$607.58M$671.03M$766.83M$860.64M$1.01B
Operating income$91.85M$43.19M$84.91M$129.18M$223.16M$260.46M$296.82M$255.37M$358.30M$425.31M
Interest expense$7.14M$13.62M$15.18M$15.66M$9.36M$6.85M$8.93M$8.09M$8.29M$7.99M
Pre-tax income$85.82M$31.18M$71.75M$116.17M$217.61M$258.00M$289.09M$272.76M$386.09M$455.62M
Income tax$32.98M$14.21M$12.69M$23.95M$46.24M$60.28M$64.44M$62.91M$87.64M$111.36M
Net income$49.99M$40.48M$92.36M$110.53M$170.48M$194.65M$224.68M$209.40M$297.97M$343.97M
EBITDA$130.53M$85.45M$129.78M$180.23M$277.73M$316.45M$359.18M$327.75M$442.44M$529.63M
EPS (basic)$0.99$0.79$1.78$2.07$3.19$3.57$4.09$3.76$5.26$6.00
EPS (diluted)$0.96$0.77$1.70$1.97$3.06$3.42$3.95$3.65$5.12$5.84
Diluted shares52.13M52.83M54.40M55.98M55.79M56.92M56.87M57.32M58.24M58.87M
Gross margin18.9%17.8%19.2%20.4%21.9%23.1%22.2%20.7%20.3%20.1%
Operating margin5.6%2.7%4.8%6.3%9.3%9.9%9.8%6.9%8.5%8.5%
Net margin3.0%2.5%5.3%5.4%7.1%7.4%7.4%5.6%7.0%6.8%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$57.71M$42.34M$31.04M$59.17M$236.56M$262.20M$316.27M$509.63M$464.60M$503.88M
Short-term investments$11.55M$13.09M$8.68M$17.75M$13.45M$13.76M$15.44M$17.23M$62.26M$68.51M
Receivables$244.43M$265.07M$251.91M$308.99M$305.06M$328.73M$408.43M$485.04M$569.90M$636.99M
Total current assets$333.86M$368.08M$348.07M$411.08M$582.96M$639.71M$781.12M$1.05B$1.16B$1.27B
Goodwill$45.98M$53.10M$49.59M$54.47M$54.47M$60.47M$76.87M$76.87M$97.98M$97.98M
Total assets$1.00B$1.10B$1.18B$2.36B$2.55B$2.85B$3.45B$4.18B$4.67B$5.46B
Total current liabilities$211.93M$225.82M$269.23M$343.17M$562.40M$523.07M$582.07M$734.75M$743.43M$894.35M
Short-term debt$8.13M$9.94M$10.11M$2.70M$2.96M$3.76M$3.88M$3.95M$4.09M$4.23M
Long-term debt$275.49M$302.99M$233.13M$330.35M$117.65M$152.88M$149.27M$145.50M$141.59M$137.53M
Total debt$283.62M$312.93M$243.24M$333.05M$120.61M$156.64M$153.15M$149.45M$145.67M$141.76M
Total liabilities$540.53M$602.37M$579.62M$1.71B$1.73B$1.83B$2.20B$2.68B$2.83B$3.23B
Shareholders' equity$456.45M$492.40M$590.93M$654.20M$818.08M$1.02B$1.25B$1.49B$1.84B$2.23B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$73.89M$79.54M$210.30M$192.22M$373.35M$275.68M$272.51M$376.67M$347.19M$564.27M
Capital expenditures$65.70M$54.08M$50.89M$71.54M——————
Free cash flow$8.19M$25.46M$159.41M$120.68M$373.35M$275.68M$272.51M$376.67M$347.19M$564.27M
Investing cash flow-$210.64M-$113.18M-$151.21M-$247.01M-$58.67M-$173.91M-$186.18M-$182.70M-$390.05M-$513.18M
Financing cash flow$152.88M$18.27M-$70.34M$82.88M-$137.30M-$76.14M-$32.26M-$612.00K-$2.16M-$11.81M
Dividends paid$8.17M$8.72M$9.42M$10.19M$10.83M$11.55M$12.17M$12.89M$13.67M$14.41M
Share buybacks$30.00M$7.29M$0$6.41M$25.00M$10.12M$29.88M$0$0$20.00M
Stock-based compensation$9.10M$7.75M$8.37M$11.32M$14.52M$18.68M$22.72M$30.77M$36.23M$48.30M
Depreciation & amortization$38.68M$42.27M$44.86M$51.05M$54.57M$55.98M$62.35M$72.39M$84.14M$104.33M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.